The aim of the present study is to analyze the predictive capacity of the transcriptional expression of SEMA3F and NRP2 in determining the presence of occult lymph node metastases in patients with HNSCC. The gene discussed is SEMA3F; the disease is metastatic malignant neoplasm in the lymph nodes.